{"id":"W2911900547","doi":"10.1016/j.bpg.2019.02.005","title":"Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?","year":2019,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"Janssen Biotech; Takeda Oncology; Eli Lilly and Company; Shire; Leona M. and Harry B. Helmsley Charitable Trust; AbbVie; Alzheimer Society of B.C.; Samsung; UCB; Celgene; Gilead Sciences; GlaxoSmithKline; Pfizer; Allergan","keywords":"Fibrosis; Crohn's disease; Medicine; Disease; Inflammation; Pathophysiology; Inflammatory bowel disease; Intensive care medicine; Bioinformatics; Immunology; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01086174,0.0006523879,0.001550152,0.0002743576,0.0002485579,0.0001750196,0.001920253,0.0008265028,0.00008795322],"category_scores_gemma":[0.02271041,0.0004915027,0.0009844692,0.0002539985,0.001062939,0.00003838628,0.001895312,0.003664891,0.0009343706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001258565,"about_ca_system_score_gemma":0.002098473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003158706,"about_ca_topic_score_gemma":0.00006503334,"domain_scores_codex":[0.9794056,0.01426655,0.002019862,0.001738636,0.0008300079,0.001739342],"domain_scores_gemma":[0.9939954,0.00190438,0.0008810186,0.002049022,0.0005293302,0.0006408044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02792918,0.01359475,0.1172785,0.02812759,0.003137418,0.03431315,0.0001123111,0.0002502659,0.00003909958,0.0004484736,0.1048085,0.6699608],"study_design_scores_gemma":[0.001262261,0.001104511,0.00850803,0.001429955,0.0005705403,0.00008917656,0.0001002917,0.00005700546,8.211611e-8,0.00002996353,0.9865273,0.000320916],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01460189,0.979055,0.0001422405,0.0006935188,0.001216933,0.003635931,0.0002120721,0.00002357937,0.0004188728],"genre_scores_gemma":[0.001778002,0.9938743,0.0003624771,0.0006824431,0.001507753,0.0005592164,0.0005227606,0.0001457264,0.0005672885],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8817188,"threshold_uncertainty_score":0.9998435,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.167653898805059,"score_gpt":0.460700965816388,"score_spread":0.293047067011329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}